Weight loss is known to alter food intake and drug selfadministration, but the neural basis of this is unknown. Therefore, we studied effects of weight loss on neurochemistry of a brain mechanism involved in behavior reinforcement. In rats reduced 2&30% below normal weight, basal extracellular dopamine (DA) in the nucleus accumbens (NAC) decreased up to 50% @ < O.Ol), as measured by in vivo microdialysis.
No such change was observed in dorsal striatum (STR) or medial prefrontal cortex. In underweight rats, systemic amphetamine (1.5 mg/kg i.p.) transiently restored extracellular DA, but only to basal normal levels. Morphine (20 mg/kg i.p.) or a meal also increased DA, but the percent increase was significantly smaller in underweight than normal weight animals. Amphetamine infused locally by reverse dialysis in the NAC increased extracellular DA more in underweight animals than controls, suggesting that DA had accumulated in the presynaptic terminals. This was confirmed by finding significantly more DA in homogenized NAC micropunches of underweight rats. Receptor counts in micropunches and quantitative receptor autoradiography showed 3H-SCH23390 and 3H-spiperone D,-and D,-type binding in the NAC, STR, frontal cortex and hypothalamus did not change significantly. Locomotor activity was depressed suggesting that low DA release in the NAC may be related to energy conservation during weight loss. Low extracellular DA may also underlie the increase in food and drug intake typically observed in underweight animals and humans when they attempt to restore extracellular DA levels by natural or artificial means. [Key words: body weight, dopamine, nucleus accumbens, amphetamine, morphine, food intake, microdialysis, autoradiography, locomotion, drug abuse]
Chronic food deprivation and subsequent weight loss have been found to increase drug-seeking behavior and voluntary drug intake in animals Carroll and Stotz, 1983; Carroll; Papasava and Singer, 1985) . This robust phenom-enon generalizes across different classes of drugs (alcohol, opioids, sedatives, dissociative anesthetics, cannabinoids, stimulants), different species (primates or rodents) and various routes of administration Oei, 1983; Carroll, 1985; Papasava et al., 1986) . The reinforcing value of food-related stimuli and drug intake has been repeatedly associated in previous studies with the activity of the mesoaccumbens dopamine (DA) system (Hoebel et al., 1983 Hernandez et al., 1987; Schultz et al., 1993; Gratton, 1994; Mark et al., 1994) . Therefore, chronic food deprivation may alter basal DA release in the nucleus accumbens (NAC), which in turn may change the response of the system to different classes of drugs (i.e., psychostimulants and opiates) and to natural reinforcers such as food-related stimuli. In the present study, in vivo microdialysis was used to monitor extracellular DA in the NAC, the dorsal striatum (STR) and the medial prefrontal cortex (PFC) of underweight and control, freely moving rats. In other groups, homogenate assays were performed to measure the combined intracellular and extracellular DA pools. Since D, and D, receptors have been closely involved in the regulation of feeding behavior (Schneider et al., 1988; Angel, 1990; Clifton et al., 1991; Cooper et al., 1992; Terry and Katz, 1992; Tyrka et al., 1992) , we also used receptor binding in NAC and STR micropunches as well as quantitative receptor autoradiography to examine differences in D, and D, density as a function of weight loss.
Materials and Methods
Experimental design. A total of 105 underweight and 114 control rats were used in the series of experiments described below. Separate subjects participated in each experiment in order to avoid drug interactions. Basal locomotor activity measurements were taken from"subiects that participated in the microdialysis experiments, a total of 27 underweight and 26 controls. For each experiments, subjects were divided in two groups, underweight and control, and the protocol for weight reduction (as described below) was identical in all experiments. Two-way ANO-VA with repeated measures and post hoc Tukey tests were used for the microdialy& data to study (1) between-group differences (underweight vs control), (2) within-group time differences (before and after drug injections and meal presentations), and (3) possible interaction (weight X time) effects. One-way ANOVA with post hoc Tukey tests were used for the homogenate-assay and the autoradiography data to study between-group differences (underweight vs control).
Animals and surgery. The microdialysis probes were made of concentric 36 gauge stainless steel tubing inside of 26 gauge tubing with a 200 pm X 2 mm hollow cellulose tip that allowed diffusion of neurochemicals with a molecular weight less than 6000. The probes had a relative recovery of about 10% depending on the neurochemical (Hernandez et al., 1986) . Syringe pumps with gas-tight syringes (2.5 ml) perfused a continuous stream of Ringer's solution (146 mM NaCl; 3.9 mM KCl; 1.2 mM CaCl,, 1 mu MgCl,; pH 7.4) at a rate of 1 pl/min through the dialysis probes. The perfusate was collected in sampling vials and immediately injected in a high performance liquid chromatography system coupled with electrochemical detection (HPLC-EC).
A coulometric detector (5100A; ESA Inc.) was used to measure DA, the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) and the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA). Samples from microdialysates or homogenates (25 pl each) were injected into a 50 p,l valve loop leading to a 10 cm phase II column (Brownlee Labs) with 3.2 mm bore and 3 km, C-18 packing. The mobile phase contained 60 mh+ NaH,PO, (sodium phosphate monobasic), 100 FM EDTA, 1 mu heptanesulfonic acid, and 2% v/v methanol. The pH was adjusted to 3.6 with phosphoric acid. Output was relayed to a dual-pen chart recorder (Linseis Inc.). Neurochemicals eluted in about 25 min in the following order: DOPAC, DA, 5-HIAA, HVA. Peaks were identified by comparison to retention times of 1 pg/pl and 10 pg/pl standards injected in the HPLC on a daily basis.
An amperometric detector with dual potentiostats (EGandG Princeton Applied Research Corp.) was used to measure serotonin (5-hydroxytryptamine, 5-HT) successively at 590 mV and at 718 mV in about 10 min. Samples (20 yl) were injected in a 20 ~1 valve loop leading to a Brownlee column as described above. The mobile phase contained 116.8 mtvr NaOH, 144.7 mu monochloroacetic acid, 100 FM EDTA, 1 mM I-octanesulfonic acid, and 1.8% v/v acetonitrile. The pH was adjusted to 3.1 with monochloroacetic acid. HPLC output was relayed to a Linseis chart recorder with recording pens assigned to each of the above oxidation potentials. Serotonin peaks were identified by comparison to both the retention time and the ratio given by the two potentials for 10 pg/pl and 1 pglpl standards injected in the HPLC on a daily basis.
Chronic food deprivation and microdialysis.
Following recovery from surgery, the microdialysis rats scheduled for weight loss were given access to a restricted amount of food (5-7 gm of chow) at the onset of the dark cycle for 7-10 d until they lost 20-30% of their ad libitum weight. Probes were implanted at least 15 hr before sampling. Left and right accumbens sites were counterbalanced between animals. Microdialysis sessions took place at least 3 hr after onset of the dark cycle when rats are normally active. No food was given to either underweight or control animals for at least 3 hr before dialysis sampling to avoid changes in basal extracellular DA from spontaneous meals before microdialysis sessions. Baseline samples were collected every 30 min for 2-3 hr to establish basal extracellular DA levels. The effect of weight loss was assessed in 17 rats, with 13 others as controls maintained on ad libitum food intake. Next, one of four challenges was administered, (1) 1.5 mg/kg i.p. d-amphetamine sulfate (AMPH; Sigma Chemicals Co.) given to the same animals, (2) a 30 min infusion of AMPH (25 PM in Ringer's) by reverse dialysis into the NAC of different groups (6 underweight and 6 controls), (3) 20 mg/kg i.p. morphine sulfate (MORPH, Sigma Chemicals Co.) with 9 underweight and 16 controls, or (4) a 30 min laboratory chow meal (11 underweight and 16 controls). To test anatomical specificity, the effects of weight loss and intraperitoneal amphetamine were assessed in the straitum (10 underweight, 16 controls) and prefrontal cortex (14 underweight, 9 controls). Horizontal locomotor activity was measured by two photocell beams that divided the cage into thirds. Activity was measured in underweight rats (n = 7) and controls (n = 12) that were then given i.p. amphetamine; other groups received intraperitoneal morphine (3 underweight, 3 control) or a meal (3 underweight, 4 control). Photocell crossings were counted in 30 min time bins.
Histology.
At the end of the microdialysis experiments animals were overdosed with sodium pentobarbital and perfused with 0.9% saline followed by 4% formaldehyde in saline. The brains were removed and stored in formaldehyde for several weeks, frozen, and sectioned at 40 pm to locate the dialysis probe tract in relation to the posterior NAC.
Homogenate assay. In the experiment to measure DA in tissue micropunches, underweight rats (n = 13), after losing weight as described above, and normal weight controls (n = 15) were sacrificed in the middle of the dark cycle. For 3 d before, they were accustomed to the setting for a few minutes in order to minimize stress at the actual time of sacrifice. Brains were kept on ice for rapid dissection and the NAC and STR were each removed bilaterally from a 2 mm thick slice just anterior to the optic chiasm using a stainless steel 1.25 mm micropunch. These tissue samples were homogenized, dissolved in 0.1 N perchloric acid and 100 wM EDTA. and centrifuged for 20 min at 15.000 rom. The supernatams were analyzed for DA, 5-HT, and metabolites'by HPLC-EC. Protein levels were determined from the remaining tissue pellets with the Bio-Rad Protein Assay. Neurochemical measurements were adjusted for the amount of protein per micropunch.
Receptor binding in micropunches.
NAC and STR micropunches were derived as described above, homogenized and pre-incubated in a buffer of 50 mu Tris, 0.5 mu EDTA, and 5 mM MgSO, (18 underweight, 16 controls). These tissue samples were incubated with 1 nM 3H-SCH23390 for D,-type binding or 1 nM )H-spiperone for D,-type binding in a buffered solution containing 40 nM ketanserin; 1 pM flupenthixol was used to define nonspecific binding. The ligand bound to the membranes was separated from that remaining free in solution by filtration under reduced pressure over glass fiber filters (Creese, 1983) . Bound ligand on the filter was counted by a liquid scintillation spectrometer (Beckman Instrument Co.).
Quantitative receptor autoradiography.
Animals (seven underweight, seven controls) were sacrificed and brains were frozen in cold isopentane. Slices (20 pm thick) were cut at the level of frontal cortex, anterior NAC-STR, posterior NAC-STR and hypothalamus (lateral, ventromedial, dorsomedial, and periventricular). All slices were mounted on subbed slides for incubation. The ligands used were 1 nM 3H-SCH23390 (D,) and 1 nM 3H-spiperone (D,) in the same incubation buffer described above. After incubation for 60 min, slices were exposed on light proof Kodak D-19 film for 2-6 weeks depending on the brain site. The developed films were analyzed with the Microcomputer Imaging Device program (Imaging Res., Inc., Ontario, Canada) in order to subtract nonspecific binding of the ligand to cellular components other than the receptors of interest (Bylund and Yamamura, 1990; Kuhar and Unnerstall, 1990) .
Results

Effect of food restriction on body weight
The mean of body weights in all experiments was 501.4 2 8.7 gm for normal rats versus 386 +-9.1 gm for underweight rats (77% of own ad libitum starting weight; Fig. 1 ).
Nucleus accumbens:
effect of weight loss on basal DA Basal extracellular DA in the NAC of four groups of underweight rats was significantly below the corresponding control group in each of the four experiments [F(1,400) = 12.458, p < O.OOOS]. Restricted food intake and weight loss reduced extracellular DA to half normal in the first experiment (see baselines in Fig. 2A ). Mean basal extracellular DA in the NAC was 0.02 ? 0.002 pmol/25 ~1 sample (mean +-SEM) for underweight rats (n = 17) and 0.04 t 0.02 pmol/sample for control rats (n = 13). A two-way ANOVA with repeated measures followed by post hoc Tukey tests showed that basal DA level in the NAC was significantly lower in the underweight than the control group [F(1,28) . Grand mean body weights for the underweight and control groups. Following chronic food deprivation, the underweight group lost 23% of its ad libitum weight.
Nucleus accumbens: effects of systemic amphetamine on DA Following measurement of basal DA, systemic d-AMPH was given in both groups. After systemic AMPH (1.5 mg/kg i.p.), extracellular DA increased in both groups, but accumbens DA remained significantly lower in the underweight animals as seen in Figure 2A [0.05 + 0.01 vs 0.10 t 0.02 pmolkample; F(1,28) = 7.217, p < 0.011. Figure 3A plots the same data as percentage of mean baseline and shows that AMPH increased extracellular DA significantly in both groups [F(13,364) = 11.57, p < 0.011 and similarly in both groups (263.8 k 57.6% for underweight vs 241 2 56.2% for controls).
HVA after AMPH challenge remained significantly lower in the underweight than the control group [ 1.71 2 0.30 vs 4.35 t 1.10 pmolkample; F( 1,27) = 8.143, p < 0.011, although AMPH decreased HVA significantly and similarly in both groups [to 52.2 2 8.8% and 55.8 k 14.2% of mean baseline in underweight and controls respectively; F(13,351) = 10.219, p < 0.011. DOPAC also decreased significantly and similarly in both groups [to 49.3 k 13% and 45.7 5 10.2% of mean baseline in underweight and controls respectively; F(13,351) = 14.139, p < 0.011. 5-HIAA levels did not change significantly in either group after AMPH.
In summary, the underweight group had low extracellular DA in the NAC, and 1.5 mg/kg AMPH transiently restored it to baseline.
Nucleus accumbens: effects of local amphetamine on DA In separate groups of animals basal DA was 68% of normal in the underweight group, and local AMPH infusion in the NAC by reverse dialysis (25 p.M in probe Ringer's) for 30 min increased extracellular DA significantly over baseline in both groups [F(7,70) = 12.704, p < 0.011, but it caused a significantly larger increase in the underweight animals [n = 6 underweight and 6 controls; 1824.6 ? 556.4% vs 595.9 ? 275.6% of mean baseline respectively; F(7,70) = 4.061, p < 0.01; Fig.  3B ]. Thus underweight rats released more DA than controls when the AMPH was applied directly to the terminal region in the NAC. Figure   2 . A, Note first that basal extracellular DA (to the left of the arrow) was low in the NAC of the underweight group (*, p < 0.01). Systemic amphetamine (arrow) increased DA significantly in both groups, but DA remained significantly lower in the underweight group. Basal and AMPH-challenged DA in the dorsal STR (B) and medial prefrontal cortex (C) did not vary as a function of body weight. Figure 3. Although the maximum DA level in response to systemic amphetamine was lower in underweight than in control rats (shown Fig.   2A ), the relative change plotted as percent change from baseline was similar in the two groups (A). In contrast, AMPH infused locally into the NAC (B) caused a much stronger response in the underweight than in the control group (*, p < 0.01).
MINUTES
Nucleus accumbens: effects of systemic morphine on DA MORPH was less effective in underweight animals. Basal DA was significantly below normal (60%), and as shown in Figure  4A , systemic MORPH (20 mgikg i.p.) increased extracellular DA significantly in both groups [234.9 ? 70% in underweight rats, IZ = 9 vs 446.3 +-122.3%, IZ = 16 in controls, F(11,253) = 8.971, p < 0.011. This percent increase was significantly less in the underweight group [F(11;253) = 2.5 12, p < 0.011. MORPH produced a significant increase in all three metabolites in both groups. Specifically, DOPAC increased to 198.1 2 55.3% of mean baseline in underweight rats and 172.2 t 37.8% in controls [F(11,253) Nucleus accumbens: effects of food intake on DA A meal was like MORPH in that it was less effective in underweight animals. Basal DA was significantly below normal (SO%), and Figure 4B shows that after a 30 min meal of Purina chow pellets, DA in the NAC increased to 121.3 2 6.3% of Similarly, food intake in underweight rats failed to increase extracellular DA to the same degree as in controls. It is noteworthy that the diminished DA response was not due to a smaller size meal. The underweight rats did not seem to suffer from poststarvation anorexia, as they ate more than controls when given an ad libitum meal, but released less DA in the NAC (*, p < 0.01) baseline in underweight rats (n = ll), and to 155.1 + 17.7% of baseline in control rats (n = 16). The percent increase was significant for both groups [F(7,182) = 3.832, p < 0.011, but significantly lower for the underweight animals [F(1,26) = 9.448, p < 0.011, even though they ate more food (7.3 ? 0.5 gm) than controls (5.6 5 0.3 gm). A one-way ANOVA showed that the difference in meal size was statistically significant [F(1,25) = 10.303, p < 0.011. As a result of the meal, HVA increased to 152.5 + 28% of mean baseline in underweight rats and to 120.4 ? 23.9% of mean baseline in control rats. The increase was significant only for the underweight group [F(7,175) = 2.404, p < 0.051. DOPAC and 5-HIAA increased, but not significantly.
Striatum: basal DA and weight loss, effects of systemic AMPH Weight loss had no detectable effects in the STR. The mean basal extracellular DA in the STR of underweight rats (n = 10) was 0.06 2 0.01 pmol/sample. After AMPH (1.5 mg/kg i.p.), it increased to 0. Figure   5 . A, Locomotor activity during baseline microdialysis measurements was significantly less in underweight than in control rats (*, p < 0.01). B, The hypoactivity of underweight rats shown in A was reversed after systemic AMPH. Underweight rats seem to be behaviorally supersensitive to AMPH (*, p < 0.01) cellular DA in the STR of control rats (n = 16) was 0.04 t 0.01 pmoleskample. After systemic AMPH it increased to 0.45 t 0.05 pmoleskample. Basal and AMPH-challenged STR DA levels did not differ significantly between the two groups (Fig.  2B) , and DA increased similarly over mean baseline [F(13,247) = 86.599, p < 0.011.
In the STR, basal extracellular HVA, DOPAC, and 5-HIAA in the underweight group did not differ from control levels. After AMPH, extracellular HVA and DOPAC decreased significantly in both groups [DOPAC: 25.7 5 3.7% vs 26 t 2.9%, F(13,247) = 108.577, p < 0.01; HVA: 37.9 + 4.6% vs 44.2 t 4%, F(13,247) = 62.600, p < 0.011. 5-HIAA increased over baseline in both groups [121.8 k 10.6% vs 125.1 +-9.9%, F(13,247) = 11.238, p < 0.011.
Prefrontal cortex: effects of weight loss and systemic AMPH on DA In the PFC, mean basal extracellular DA was the same in underweight and control rats (n = 14 and n = 9, respectively). After systemic AMPH (1.5 mg/kg i.p.), DA increased equally in . The sum of extracellular and intracellular DA in NAC homogenates was higher in underweight than in control rats. Therefore, the reduced DA response shown in Figure 4 is probably due to a reduction in DA release, not in DA synthesis (*, p < 0.05).
both groups (from 0.01 to 0.04 pmolkample, [F(13,273) = 9.759, p < 0.011 as shown in Figure 2C . Extracellular HVA, DOPAC and 5-HIAA were similar in the PFC of underweight and control rats. After systemic AMPH, extracellular DOPAC and HVA decreased significantly and similarly in the PFC of underweight and control groups [DOPAC: 61.75 k 10.07% vs 63.66 k 18.1%, F(13,273) = 4.531, p < 0.01; HVA: 70.7 5 6.57% vs 74.88 + 16.18%, F(13,273) = 5.886, p < 0.011. No significant changes were observed in AMPH-challenged 5-HIAA levels.
Locomotor activity: effect of weight loss, AMPH, MORPH, and a meal Underweight animals were less active. Basal locomotor activity of underweight rats was 23 k 2 (mean 2 SEM) photocell counts130 min vs 40 t 3 for the controls [n = 27 and n = 26; one-way ANOVA: F(1,47) = 7.436, p < 0.01; Fig. 5A ]. For underweight rats given systemic AMPH (1.5 mg/kg i.p.), locomotor activity increased to 837 t 188% vs 380 -C 95% in controls [n = 7; F(13,156) = 4.760, p < 0.01; Fig. 5B ]. When given local AMPH infused into the NAC, locomotor activity again increased significantly to 180 ? 63% in the underweight group [F(7,147) = 2.748, p < 0.01; n = II], but not in the control group (n = 12).
Morphine (20 mg/kg i.p.) decreased locomotor activity to 0.7 2 0.8% of mean baseline in underweight rats (n = 3) and to 17.6 + 14% in controls (n = 3) during the first 30 min. Then, photocell crossings increased to 408.3 +-255.8% and 317.9 + 80.7%, respectively, 3 hr after the injection. Cessation of locomotion and the later hyperactivity were not different between groups.
When given access to a meal, locomotor activity increased to 561.2 + 442.2% in underweight rats (n = 3) and 352.4 ? 146.2% in controls (n = 4). This tendency to walk around the cage during eating was not significantly different between groups.
Homogenate assays for DA and 5-HT Total presynaptic and postsynaptic DA and 5-HT both increased in association with food restriction and weight loss. Mean DA in NAC homogenates was 0.068 2 0.009 pmollpg protein in underweight rats and 0.046 + 0.005 in control rats [n = 13 and 15; one-way ANOVA: F(1,24) = 5.31, p < 0.05: Fig. 61 . Similarly, 5-HT levels in NAC homogenates were significantly higher in the underweight group than in the control group [0.003 ? 0.0004 vs 0.0005 * 0.00004 pmol/pg protein; F(1,20) = 39.544, p < 0.011. Although total DA and 5-HT were high, DOPAC, HVA, and 5-HIAA were normal.
In the STR, homogenate DA, 5-HT, DOPAC, and 5-HIAA were similar in underweight and control rats but striatal HVA levels were significantly lower [0.006 -+ 0.001 pmol/kg protein compared to 0.01 + 0.001 in controls; F(1,27) = 6.782, p < 0.051.
The Journal of Neuroscience, October 1995, 75(10) 6645 Quantitative receptor autoradiography No differences were seen in mean D, or D,-type binding in NAC, dorsomedial STR (DMSTR), medial STR (MSTR), dorsolateral STR (DLSTR), frontal cortex (CX), dorsomedial hypothalamus (DMH), ventromedial hypothalamus (VMH), paraventricular nucleus of the hypothalamus (PVN), and lateral hypothalamus (LH) of underweight (n F 7) and control rats (n = 7; Tables 1, 2; Fig. 7AJ ).
Discussion
Following chronic food deprivation and body weight reduction to 70-80% of normal, basal extracellular DA in the NAC, but not in the STR or the PFC, decreased 20-50%. The reduction in basal DA levels was accompanied by a significant reduction in HVA levels, which suggests that extracellular DA turnover was low in underweight rats. This between-group study replicates and extends an earlier preliminary report ) and within-group study showing the effect of weight loss on DA in the NAC (Pothos et al., 1989, in press; . The low extracellular DA levels could theoretically reflect a variety of changes such as (1) increased intracellular DA metabolism, (2) attenuation in DA synthesis, (3) amplification of the active reuptake process, or (4) simply a decrease in DA release. Extracellular DOPAC is thought ta reflect changes in the intracellular DA pool (Zetterstrom et al., 1986) . Therefore, in the present study, the absence of a significant reduction in DOPAC levels suggests that intracellular DA levels were not reduced by chronic food deprivation and weight loss. To the contrary, the overall sum of extracellular and intracellular DA in NAC homogenates was higher in underweight animals than in controls, suggesting DA was synthesized but not released, so that it accumulated in the DA neurons. The DA uptake transporter could contribute by maintaining storage pools (Horn, 1990) . The whole process is related to the firing rate of relevant midbrain DA cell bodies. Firing at a lower rate in underweight rats would release less DA in the NAC and explain the observed results. The absence of an effect in the STR or the PFC is interesting and may be an indication that the VTA-NAC pathway mediates some unique aspect of motivation as it relates to food restriction and weight loss.
Receptor binding in NAC micropunches and quantitative au- toradiography revealed no differences in DA receptor density between normal and underweight rats. Therefore the depression in extracellular DA levels seems to be related to attenuated presynaptic transmitter release that was not accompanied by postsynaptic supersensitivity in the receptors that were measured. Although D,-and D,-type receptor densities are often affected by changes in DA turnover, blockade or denervation (Weinstock et al., 1978; LaHoste and Marshall, 1991) , this was not detected in rats with low extracellular DA produced by the natural means of food restriction and weight loss. In spite of the apparent lack of receptor upregulation, there could be receptor supersensitivity after starvation. SCH23390 and spiperone bind D,-and D,-type receptors nonselectively within each receptor family. Therefore changes in the density of receptor subtypes within the D, family (D,, DJ, or D, family (D,, D,, D,) may be difficult to detect if the relevant change occurs in a small, select portion of the receptors. In addition, D,-type and D,-type receptors within mesolimbic areas have high DA affinity that can change without a change in receptor density (Snyder, 1990; Sokoloff et al., 1990; Grandy et al., 1991; Sunahara et al., 1991; Levesque et al., 1992) . Decreased stimulation of D, receptors, however, does not necessarily increase D, sensitivity due to an unknown compensatory mechanism (Mereu et al., 1987) . In sum, changes in DA receptor number are not always reflected in behaviors mediated by DA, and behavioral signs of DA receptor supersensitivity are not necessarily accompanied by changes in receptor density (Eisenberg et al., 1982; Segal and Kuczenski, 1992; Reddy et al., 1993) . On the other hand, the apparent lack of D,-and D,-type compensation for decreased extracellular DA in the NAC in the present study is perfectly compatible with the fact that underweight animals engage in more behaviors that release DA from presynaptic stores (i.e., more feeding or drug intake). If receptors compensated for decreased DA release, one would not expect an increase in DA-releasing behaviors.
Given the involvement of mesoaccumbens DA in the mediation of food and drug reinforcement, the selective reduction of basal DA in the NAC of underweight rats may code a motivational state associated with starvation and conducive to eating and drug intake. Some models of feeding disorders suggest that starvation and refeeding may lead to "addiction" to certain eating practices that involve a state of "food withdrawal" (Bachmann and Rohr, 1983; Szmukler and Tantam, 1984; Ploog and Pirke, 1987; Hoebel et al., 1992) . Viewing starvation as a withdrawal syndrome is interesting in the light of evidence that extracellular accumbens DA is also low in rats undergoing morphine, ethanol, cocaine, or AMPH withdrawal (Pothos et al., 1991; Acquas and Di Chiara, 1992; Rossetti et al., 1992; Persico et al., 1993) . The DA depression in underweight rats may relate to aversive properties of food withdrawal or to chronic stress associated with starvation. Although acute stressors, such as tail pinch, foot shock or restraint have been found to increase DA in the NAC (Abercrombie et al., 1989; Salamone, 1991; Imperato et al., 1992) , repeated exposure to stress can attenuate the DA response and even decrease the activity of DA neurons (Imperato et al., 1992; Sato and Kumamoto, 1992) . Low DA may contribute to locomotor inactivity and aversive states associated with those stressors.
In the present experiments, underweight animals were hypoactive in comparison to controls. Other studies report that fasting also dampens the sympathetic nervous system in rodents (Griggio et al., 1992) . According to Mabry and Campbell (1975) food-deprived rats become hyperactive only when a novel stimulus (i.e., light, food or drug injection) is introduced'in their environment. Indeed, we observed a significant increase in the locomotor activity of the underweight group versus the control group after systemic AMPH or local AMPH infusion in the NAC. Low sympathetic activity and selective low DA release in the NAC may be signs that the animal is in a "no-go" state characterized by hypoactivity and lack of goal-oriented behaviors. The seeking of food reward and avoidance of starvation aversion cannot be controlled by the animals in this paradigm because the experimenter regulates food access. Therefore, it is to the animals' advantage to conserve energy. The selective depression in accumbens DA may mediate such a motivational "no-go" state. However, we hypothesize that a higher level of DA release in the NAC is preferred because it is known that they voluntarily self-inject AMPH or DA into their NAC (Hoebe1 et al., 1983 , Dworkin et al., 1985 . Consequently, when underweight rats are presented with the prospect of a meal or familiar drug self-injection, they may switch to a motivational "go" state initiated by classically conditioned stimuli that release DA (Mark et al., 1994) . Then, they would actively seek out reinforcing stimuli (Robinson and Berridge, 1993) , which might further increase accumbens DA release.
The mesoaccumbens DA system was challenged in our experiments with systemic and local AMPH, systemic morphine, and food intake. In a preliminary study AMPH appeared to lose its DA-releasing effectiveness in underweight rats (Hemandez and Hoebel 1990) ; however, in the present study AMPH effectively increased extracellular DA, but only up to the baseline. Given that AMPH can lead to the inhibition of dopamine cells in the midbrain it was interesting to test the drug locally in the NAC. In contrast to systemic injections, local infusions of AMPH directly into the NAC caused greater DA release in underweight rats than in controls. This corresponds to what is known about AMPH's mechanism of action. It has been shown in vitro, and we have shown in vivo by microdialysis, that the drug primarily releases vesicular DA into the cytosol through vesicle deacidification (Sulzer and Rayport, 1990; Sulzer et al., 1992; Seiden et al., 1993) . The elevated cytosolic DA pool is then released into the extracellular space through the DA transporter acting in reverse (Sulzer et al., 1993) . Therefore, local AMPH-induced DA release will be higher than normal if the presynaptic stores are higher than normal, as was the case in the NAC of underweight rats in this study.
Morphine and food intake caused a smaller percentage increase in extracellular DA in underweight compared to normal rats. The underweight rats ate a bigger size meal than the controls, even though the DA response was weaker. We hypothesize that underweight animals may increase drug or food intake in order to receive DA-mediated reinforcement, and for that purpose they elevate drug-oriented and food-oriented responding and intake in self-administration paradigms. The literature suggests that animals titrate their drug intake (Yokel and Pickens, 1973) . Rats self-injecting d-amphetamine directly into the accumbens decreased their response rate to half when half the baseline drug intake was provided automatically (Hoebel et al., 1983) . The present results imply that starved, underweight animals, including people, may eat food and take drugs of abuse partly because their mesoaccumbens DA system is depressed and extracellular DA is low in the NAC. The consequence of their actions is to increase extracellular DA, but not as high as under normal conditions, which further amplifies their DA-re-leasing behavior. If the drug happens to be an appetite suppressant, like AMPH or cocaine, then body weight would not readily be restored, and this link between low weight and the need for DA would exacerbate the psychostimulant self-administration. However, it should be noted that chronic starvation is a complex syndrome, and therefore merits consideration beyond its selective effects on accumbens DA. For example, 5-HT in NAC micropunches was higher in underweight than in control rats, although in another study extracellular 5-HT was nearly normal (Pothos et al., in press) . The brain appears to defend extracellular 5-HT during food restriction. Interactions between dopaminergic, serotonergic, and other neurochemical and endocrine systems should be carefully considered before the connection between undernutrition, weight loss, and drug self-administration is to be fully understood.
